Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.20.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Treasury Stock
Common stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning at Sep. 30, 2018   $ 573 $ (517) $ (41,952) $ (41,896)
Balance, beginning, shares at Sep. 30, 2018   5,727,090      
Stock-based compensation expense     1,547,474   1,547,474
Issuance of restricted stock for services   $ 151 1,323   1,474
Issuance of restricted stock for services (in shares)   1,517,792      
Repurchase of common stock $ (140)   126   (14)
Repurchase of common stock (in shares) (1,401,202)        
Retirement of common stock $ 140 $ (140)      
Retirement of common stock (in shares) 1,401,202 (1,401,202)      
Common stock for research and development expense- license acquired   $ 84 844,516   844,600
Common stock for research and development expense- license acquired (in shares)   835,625      
Cash received for prefunded warrants     10   10
Net loss       (3,518,298) (3,518,298)
Balance, ending at Mar. 31, 2019   $ 668 2,392,932 (3,560,250) (1,166,650)
Balance, ending, shares at Mar. 31, 2019   6,679,305      
Balance, beginning at Dec. 31, 2018 $ (140) $ 573 1,137,512 (1,530,440) (392,495)
Balance, beginning, shares at Dec. 31, 2018 (1,401,202) 5,727,090      
Stock-based compensation expense     1,254,171   1,254,171
Issuance of restricted stock for services   $ 151 1,323   1,474
Issuance of restricted stock for services (in shares)   1,517,792      
Issuance of common stock for research and development expense- license acquired   $ 84 (84)    
Issuance of common stock for research and development expense- license acquired (in shares)   835,625      
Retirement of common stock $ 140 $ (140)      
Retirement of common stock (in shares) 1,401,202 (1,401,202)      
Cash received for prefunded warrants     10   10
Net loss       (2,029,810) (2,029,810)
Balance, ending at Mar. 31, 2019   $ 668 2,392,932 (3,560,250) (1,166,650)
Balance, ending, shares at Mar. 31, 2019   6,679,305      
Balance, beginning at Sep. 30, 2019   $ 1,708 37,027,875 (27,000,199) $ 10,029,384
Balance, beginning, shares at Sep. 30, 2019   17,077,873     17,077,873
Stock-based compensation expense     2,843,636   $ 2,843,636
Issuance of restricted stock for services (in shares)   2,752      
Net loss       (8,883,820) (8,883,820)
Balance, ending at Mar. 31, 2020 $ 0 $ 1,708 39,871,511 (35,884,019) $ 3,989,200
Balance, ending, shares at Mar. 31, 2020 0 17,080,625     17,080,625
Balance, beginning at Dec. 31, 2019 $ 0 $ 1,708 38,532,101 (31,505,749) $ 7,028,060
Balance, beginning, shares at Dec. 31, 2019 0 17,077,873      
Stock-based compensation expense $ 0 $ 0 1,339,410 0 1,339,410
Issuance of restricted stock for services   $ 0 0 0 0
Issuance of restricted stock for services (in shares)   2,752      
Net loss 0 $ 0 0 (4,378,270) (4,378,270)
Balance, ending at Mar. 31, 2020 $ 0 $ 1,708 $ 39,871,511 $ (35,884,019) $ 3,989,200
Balance, ending, shares at Mar. 31, 2020 0 17,080,625     17,080,625